Kennerly Patrick to Methylphenidate
This is a "connection" page, showing publications Kennerly Patrick has written about Methylphenidate.
Connection Strength
7.281
-
Potential for Underestimation of d-Methylphenidate Bioavailability Using Chiral Derivatization/Gas Chromatography. Drug Metab Dispos. 2019 07; 47(7):764-767.
Score: 0.583
-
Drug Regimen Individualization for Attention-Deficit/Hyperactivity Disorder: Guidance for Methylphenidate and Dexmethylphenidate Formulations. Pharmacotherapy. 2019 06; 39(6):677-688.
Score: 0.566
-
Absorption Differences between Immediate-Release Dexmethylphenidate and dl-Methylphenidate. Drug Metab Dispos. 2016 Mar; 44(3):418-21.
Score: 0.463
-
Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus Methylphenidate. J Clin Psychopharmacol. 2015 Aug; 35(4):464-7.
Score: 0.450
-
Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker. J Pharm Sci. 2014 Dec; 103(12):3834-3842.
Score: 0.425
-
Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability. J Child Adolesc Psychopharmacol. 2013 Dec; 23(10):648-54.
Score: 0.400
-
Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans. Drug Metab Dispos. 2013 Jan; 41(1):197-205.
Score: 0.371
-
Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice. Psychopharmacology (Berl). 2013 Feb; 225(3):613-25.
Score: 0.368
-
Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery. Pharmacol Biochem Behav. 2011 Dec; 100(2):264-70.
Score: 0.343
-
Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations. J Pharm Sci. 2011 Jul; 100(7):2966-78.
Score: 0.328
-
The interactive effects of methylphenidate and ethanol on ethanol consumption and locomotor activity in mice. Pharmacol Biochem Behav. 2010 May; 95(3):267-72.
Score: 0.307
-
Evolution of stimulants to treat ADHD: transdermal methylphenidate. Hum Psychopharmacol. 2009 Jan; 24(1):1-17.
Score: 0.285
-
Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? J Clin Psychopharmacol. 2008 Jun; 28(3 Suppl 2):S54-61.
Score: 0.274
-
Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 01; 862(1-2):140-9.
Score: 0.265
-
Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 2007 Mar; 81(3):346-53.
Score: 0.251
-
Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity. Behav Pharmacol. 2007 Feb; 18(1):39-51.
Score: 0.250
-
Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. J Med Chem. 2005 Apr 21; 48(8):2876-81.
Score: 0.221
-
New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Drug Deliv. 2005 Jan; 2(1):121-43.
Score: 0.216
-
Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations. Pharmacotherapy. 2003 Oct; 23(10):1281-99.
Score: 0.198
-
Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism. Clin Pharmacol Ther. 2022 04; 111(4):878-885.
Score: 0.174
-
Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers. J Clin Psychopharmacol. 2017 Aug; 37(4):419-428.
Score: 0.129
-
Enantiospecific determination of DL-methylphenidate and DL-ethylphenidate in plasma by liquid chromatography-tandem mass spectrometry: application to human ethanol interactions. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Apr 01; 879(11-12):783-8.
Score: 0.083
-
The discriminative stimulus properties of methylphenidate in C57BL/6J mice. Behav Pharmacol. 2011 Feb; 22(1):14-22.
Score: 0.082
-
A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Oct 15; 858(1-2):91-5.
Score: 0.065
-
A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol. 2006 Dec; 16(6):687-98.
Score: 0.062
-
The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine. Drug Metab Dispos. 2006 Jul; 34(7):1116-21.
Score: 0.059
-
Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Clin Pharmacokinet. 2003; 42(4):393-401.
Score: 0.047
-
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am J Hum Genet. 2008 Jun; 82(6):1241-8.
Score: 0.017